Acute Coronary Syndrome After Transcatheter Aortic Valve Implantation (Results from Over 40,000 Patients)

T Ogami, DE Kliner, C Toma, S Sanon… - The American Journal of …, 2023 - Elsevier
Acute coronary syndrome (ACS) encompasses a broad category of presentations from
unstable angina to ST-elevation myocardial infarctions. Most patients undergo coronary …

[HTML][HTML] Management of coronary artery disease in patients with aortic stenosis in the era of transcatheter aortic valve replacement

AD Belur, N Solankhi, R Sharma - Frontiers in Cardiovascular …, 2023 - frontiersin.org
Aortic stenosis (AS) is a common valve disorder among the elderly and these patients
frequently have concomitant coronary artery disease (CAD). Risk factors for calcific AS are …

Acute coronary syndrome following transcatheter aortic valve replacement

M Zivkovic, S Tomovic, I Busic, K Zivic… - Current Problems in …, 2023 - Elsevier
Extending the indication of transcatheter aortic valve replacement (TAVR) to younger and
lower-risk patients naturally results in longer life expectancy and survival rates after the …

[HTML][HTML] New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort

O Koren, V Patel, R Naami, E Naami… - Frontiers in …, 2022 - frontiersin.org
OBJECTIVE: To assess the incidence of new adverse coronary events (NACE) following
transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR. BACKGROUND …

[HTML][HTML] Transcatheter Aortic Valve Replacement for Failed Surgical or Transcatheter Bioprosthetic Valves: A Comprehensive Review

T Groginski, A Mansour, D Kamal, M Saad - Journal of Clinical Medicine, 2024 - mdpi.com
Transcatheter aortic valve replacement (TAVR) has proven to be a safe, effective, and less
invasive approach to aortic valve replacement in patients with aortic stenosis. In patients …

Coronary Artery Obstruction After Transcatheter Aortic Valve Implantation: Past, Present, and Future

H Ibrahim, A Chaus, A Alkhalil, L Prescher… - Circulation …, 2024 - Am Heart Assoc
Coronary obstruction (CO) is a rare but critical complication of transcatheter aortic valve
implantation. It is associated with significant morbidity and mortality. This comprehensive …

Contemporary issues and lifetime management in patients underwent transcatheter aortic valve replacement

K Matsushita, O Morel, P Ohlmann - Cardiovascular Intervention and …, 2023 - Springer
Latest clinical trials have indicated favorable outcomes following transcatheter aortic valve
replacement (TAVR) in low surgical risk patients with severe aortic stenosis. However, there …

Impact of same-admission percutaneous coronary intervention on periprocedural outcomes of transcatheter aortic valve implantation

DY Park, S An, AW Arif, A Saini… - Baylor University Medical …, 2024 - Taylor & Francis
Background Current guidelines recommend percutaneous coronary intervention (PCI) prior
to transcatheter aortic valve implantation (TAVI) if significant coronary artery disease is …

[HTML][HTML] Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls

KS Mylonas, DC Angouras - Journal of Clinical Medicine, 2023 - mdpi.com
This review explores the use of bioprosthetic valves for the lifetime management of patients
with aortic stenosis, considering recent advancements in surgical (SAV) and transcatheter …

Early offering transcatheter aortic valve replacement to patients with moderate aortic stenosis: quantifying costs and benefits–a Markov model-based simulation study

D Nguyen, T Marwick, M Moodie, L Gao - BMJ open, 2023 - bmjopen.bmj.com
Objective Aortic stenosis (AS) is one of the most common acquired cardiac valvular
diseases. The success of transcatheter aortic valve implantation (TAVI) for severe AS has …